SCHEMBL13775974

SCHEMBL13775974

Cc1c(F)cccc1C(O)c1cc(Cl)ccc1NC(=O)OC(C)(C)C

nearest known ligand 0.40

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
HSP90AA1 P07900 1/20 0.40
HSP90AB1 P08238 1/20 0.40
MEN1 O00255 1/20 0.38
ALDH1A1 P00352 1/20 0.38
LMNA P02545 1/20 0.38
MAPT P10636 1/20 0.38
KMT2A Q03164 1/20 0.38
NPSR1 Q6W5P4 1/20 0.38
CYP17A1 P05093 1/20 0.37
LPAR1 Q92633 3/20 0.36
S1PR3 Q99500 1/20 0.36
RXFP1 Q9HBX9 1/20 0.36
P2RX3 P56373 2/20 0.36
KCNQ4 P56696 3/20 0.36
KCNQ5 Q9NR82 3/20 0.36
USP30 Q70CQ3 1/20 0.35
ELANE P08246 1/20 0.35
CTRB1 P17538 1/20 0.35
FDFT1 P37268 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13776193 0.90 HSP90AA1 (0.41) HSP90AA1HSP90AB1CYP17A1LPAR1S1PR3
SCHEMBL4124330 0.88 LPAR1 (0.40) HSP90AA1HSP90AB1ALDH1A1CYP17A1LPAR1
SCHEMBL4119701 0.86 LPAR1 (0.45) HSP90AA1HSP90AB1MEN1ALDH1A1LMNA
SCHEMBL4125981 0.85 KMT2A (0.42) MEN1ALDH1A1LMNAMAPTKMT2A
SCHEMBL13776189 0.84 HSP90AA1 (0.44) HSP90AA1HSP90AB1MEN1KMT2ALPAR1
SCHEMBL4113235 0.83 LPAR1 (0.44) HSP90AA1HSP90AB1MEN1ALDH1A1MAPT
SCHEMBL19939487 0.82 HSP90AA1 (0.39) HSP90AA1HSP90AB1MEN1ALDH1A1MAPT
SCHEMBL4122839 0.82 LMNA (0.46) HSP90AA1HSP90AB1ALDH1A1LMNAMAPT
SCHEMBL13776424 0.82 HSP90AA1 (0.43) HSP90AA1HSP90AB1MEN1ALDH1A1KMT2A
SCHEMBL4119464 0.81 LPAR1 (0.51) HSP90AA1HSP90AB1MEN1ALDH1A1LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090181942-A1 TRICYCLIC COMPOUNDS DAIICHI SANKYO COMPANY, LIMITED (JP) 2009-07-16 US disclosed
US-20090181942-A1 TRICYCLIC COMPOUNDS DAIICHI SANKYO COMPANY, LIMITED (JP) 2009-07-16 US disclosed
EP-1939205-A1 TRICYCLIC COMPOUND Daiichi Sankyo Company, Limited (JP) 2008-07-02 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090181942-A1 TRICYCLIC COMPOUNDS FDFT1, COASY, HMGCR HSP90AA1 4018/4885HSP90AB1 3883/4885MEN1 2041/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.